International distribution and age estimation of the Portuguese BRCA2 c.156-157insAlu founder mutation

Breast Cancer Research and Treatment

Volumn 127, Issue 3, 2011, Pages 671-679

  Peixoto, Ana ^a   Santos, Catarina ^a   Pinheiro, Manuela ^a   Pinto, Pedro ^a   Soares, Maria José ^a   Rocha, Patrícia ^a   Gusmão, Leonor ^b   Amorim, António ^b   Van Der Hout, Annemarie ^c   Gerdes, Anne Marie ^d,e   Thomassen, Mads ^d   Kruse, Torben A ^d   Cruger, Dorthe ^f   Sunde, Lone ^g   Bignon, Yves Jean ^h   Uhrhammer, Nancy ^h   Cornil, Lucie ^h   Rouleau, Etienne ⁱ   Lidereau, Rosette ⁱ   Yannoukakos, Drakoulis ^j   Pertesi, Maroulio ^j   Narod, Steven ^k   Royer, Robert ^k   Costa, Maurício M ^l   Lazaro, Conxi ^m   Feliubadaló, Lidia ^m   Graña, Begoña ^m   Blanco, Ignacio ^m   De La Hoya, Miguel ⁿ   Caldés, Trinidad ⁿ   Maillet, Philippe ^o   Benais Pont, Gaelle ^o   Pardo, Bruno ^o   Laitman, Yael ^p   Friedman, Eitan ^p   Velasco, Eladio A ^q   Durán, Mercedes ^q   Miramar, Maria Dolores ^r   Valle, Ana Rodriguez ^r   Calvo, María Teresa ^r   Vega, Ana ^s   Blanco, Ana ^s   Diez, Orland ^t,u   Gutiérrez Enríquez, Sara ^u   Balmaña, Judith ^t   Ramon Y Cajal, Teresa ^v   Alonso, Carmen ^v   Baiget, Montserrat ^v   Foulkes, William ^w,x   Tischkowitz, Marc ^w,x   Kyle, Rachel ^w,x   Sabbaghian, Nelly ^w,x   Ashton Prolla, Patricia ^y,z   Ewald, Ingrid P ^y,z   Rajkumar, Thangarajan ^aa   Mota Vieira, Luisa ^ab   Giannini, Giuseppe ^ac   Gulino, Alberto ^ac   Achatz, Maria I ^ad   Carraro, Dirce M ^ad   De Paillerets, Brigitte Bressac ^ae   Remenieras, Audrey ^ae   Benson, Cindy ^af   Casadei, Silvia ^ag   King, Mary Claire ^ag   Teugels, Erik ^ah   Teixeira, Manuel R ^a,b   more..

^a PORTUGUESE ONCOLOGY INSTITUTE   (Portugal)

^b UNIVERSITY OF PORTO   (Portugal)

^c UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^d ODENSE UNIVERSITY HOSPITAL   (Denmark)

^e Rigshospitalet   (Denmark)

^f LILLEBAELT HOSPITAL   (Denmark)

^g AARHUS UNIVERSITY HOSPITAL   (Denmark)

^h CENTRE JEAN PERRIN   (France)

ⁱ INSTITUT CURIE   (France)

^j INSTITUTE OF NANOSCIENCE AND NANOTECHNOLOGY   (Greece)

^k UNIVERSITY OF TORONTO   (Canada)

^l FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^m HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

ⁿ HOSPITAL CLÍNICO SAN CARLOS   (Spain)

^o GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^p GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^q Universidad de Valladolid y Consejo Superior de Investigaciones Científicas   (Spain)

^r HOSPITAL UNIVERSITARIO MIGUEL SERVET   (Spain)

^s CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^t HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^u VALL D HEBRON UNIVERSITY HOSPITAL   (Spain)

^v Hospital Sant Pau   (Spain)

^w MCGILL UNIVERSITY   (Canada)

^x MCGILL UNIVERSITY   (Canada)

^y FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

^z HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

^aa CANCER INSTITUTE WIA   (India)

^ab Hospital of Divino Espirito Santo of Ponta Delgada   (Portugal)

^ac SAPIENZA UNIVERSITY OF ROME   (Italy)

^ad A C CAMARGO CANCER CENTER   (Brazil)

^ae INSTITUT GUSTAVE ROUSSY   (France)

^af RHODE ISLAND HOSPITAL   (United States)

^ag UNIVERSITY OF WASHINGTON   (United States)

^ah VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

more..

Author keywords

Age estimation; c.156 157insAlu BRCA2 mutation; Founder mutation; Hereditary breast ovarian cancer

Indexed keywords

RNA;

AGE DISTRIBUTION; ALU SEQUENCE; ARTICLE; BREAST CANCER; BREAST CARCINOGENESIS; CONTROLLED STUDY; ETHNICITY; EXON; FAMILIAL CANCER; FRANCE; GENE DELETION; GENE MUTATION; GENE REARRANGEMENT; GENETIC SCREENING; HAPLOTYPE; HEREDITARY BREAST OVARIAN CANCER; HUMAN; IMMIGRANT; MAJOR CLINICAL STUDY; OVARY CANCER; PORTUGAL; PORTUGUESE; PRIORITY JOURNAL; RNA TRANSCRIPTION; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR SUPPRESSOR GENE; UNITED STATES;

AMINO ACID SEQUENCE; BREAST NEOPLASMS; FEMALE; FOUNDER EFFECT; GENES, BRCA2; GENETIC PREDISPOSITION TO DISEASE; GENETIC TESTING; GENETICS, POPULATION; HUMANS; MICROSATELLITE REPEATS; MUTATION; OVARIAN NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; PORTUGAL; READING FRAMES; RNA, MESSENGER; SEQUENCE DELETION;

EID: 79958280483     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-010-1036-3     Document Type: Article

References (16)

1. R Ferla V Calo S Cascio G Rinaldi G Badalamenti I Carreca E Surmacz G Colucci V Bazan A Russo 2007 Founder mutations in BRCA1 and BRCA2 genes Ann Oncol 18 93 98 10.1093/annonc/mdm234
2. JD Fackenthal OI Olopade 2007 Breast cancer risk associated with BRCA1 and BRCA2 in diverse populations Nat Rev Cancer 7 12 937 948 18034184 10.1038/nrc2054 1:CAS:528:DC%2BD2sXhtlCrsLbK (Pubitemid 350165853)
3. S Filippini A Blanco A Fernandez-Marmiesse V Alvarez-Iglesias C Ruiz-Ponte A Carracedo A Vega 2007 Multiplex SNaPshot for detection of BRCA1/2 common mutations in Spanish and Spanish related breast/ovarian cancer families BMC Med Genet 8 40
4. E Teugels S De Brakeleer G Goelen W Lissens E Sermijn J De Greve 2005 De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes Hum Mutat 26 3 284 16088935 10.1002/humu.9366
5. PM Machado RD Brandao BM Cavaco J Eugenio S Bento M Nave P Rodrigues A Fernandes F Vaz 2007 Screening for a BRCA2 rearrangement in high-risk breast/ovarian cancer families: evidence for a founder effect and analysis of the associated phenotypes J Clin Oncol 25 15 2027 2034 17513806 10.1200/JCO.2006.06.9443 1:CAS:528:DC%2BD2sXmvVWms74%3D (Pubitemid 46972787)
6. A Peixoto C Santos P Rocha M Pinheiro S Principe D Pereira H Rodrigues F Castro J Abreu L Gusmao A Amorim MR Teixeira 2009 The c.156-157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal Breast Cancer Res Treat 114 1 31 38 10.1007/s10549-008-9978-4 1:CAS:528:DC%2BD1MXhtVehsL8%3D
7. O Diez S Gutierrez-Enriquez T Ramon y Cajal C Alonso J Balmana G Llort 2007 Caution should be used when interpreting alterations affecting the exon 3 of the BRCA2 gene in breast/ovarian cancer families J Clin Oncol 25 31 5035 5036 17971607 10.1200/JCO.2007.13.4346 (Pubitemid 350220441)
8. A Peixoto C Santos P Rocha P Pinto S Bizarro MR Teixeira 2009 Molecular diagnosis of the Portuguese founder mutation BRCA2 c.156-157insAlu Breast Cancer Res Treat 117 1 215 217 18853249 10.1007/s10549-008-0214-z
9. A Peixoto N Salgueiro C Santos G Varzim P Rocha MJ Soares D Pereira H Rodrigues MJ Bento A Fraguas G Moura F Regateiro S Castedo MR Teixeira 2006 BRCA1 and BRCA2 germline mutational spectrum and evidence for genetic anticipation in Portuguese breast/ovarian cancer families Fam Cancer 5 4 379 387 16826315 10.1007/s10689-006-0009-5 1:CAS:528:DC%2BD28Xht1yktbjO (Pubitemid 44924115)
10. TD Schmittgen KJ Livak 2008 Analyzing real-time PCR data by the comparative C(T) method Nat Protoc 3 6 1101 1108 18546601 10.1038/nprot.2008.73 1:CAS:528:DC%2BD1cXmvVemt7c%3D (Pubitemid 351818697)
11. S Martins F Calafell C Gaspar VC Wong I Silveira GA Nicholson ER Brunt L Tranebjaerg G Stevanin M Hsieh BW Soong L Loureiro A Durr S Tsuji M Watanabe LB Jardim P Giunti O Riess LP Ranum A Brice GA Rouleau P Coutinho A Amorim J Sequeiros 2007 Asian origin for the worldwide-spread mutational event in Machado-Joseph disease Arch Neurol 64 10 1502 1508 17923634 10.1001/archneur.64. 10.1502 (Pubitemid 47572674)
12. Gyapay G, Morissette J, Vignal A, Dib C, Fizames C, Millasseau P, Marc S, Bernardi G, Lathrop M, Weissenbach J (1994) The 1993-94 Genethon human genetic linkage map. Nat Genet 7. doi: 10.1038/ng0694supp-246
13. D Ford DF Easton M Stratton S Narod D Goldgar P Devilee DT Bishop B Weber G Lenoir J Chang-Claude H Sobol MD Teare J Struewing A Arason S Scherneck J Peto TR Rebbeck P Tonin S Neuhausen R Barkardottir J Eyfjord H Lynch BA Ponder SA Gayther M Zelada-Hedman, et al. 1998 Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium Am J Hum Genet 62 3 676 689 9497246 10.1086/301749 1:CAS:528:DyaK1MXlvFeh (Pubitemid 28164626)
14. C Santos A Peixoto P Rocha A Vega MJ Soares N Cerveira S Bizarro M Pinheiro D Pereira H Rodrigues F Castro R Henrique MR Teixeira 2009 Haplotype and quantitative transcript analyses of Portuguese breast/ovarian cancer families with the BRCA1 R71G founder mutation of Galician origin Fam Cancer 8 3 203 208 19123044 10.1007/s10689-008-9229-1 1:CAS:528:DC%2BD1MXptVGqsb8%3D
15. J McClellan MC King 2010 Genetic heterogeneity in human disease Cell 141 2 210 217 20403315 10.1016/j.cell.2010.03.032 1:CAS:528:DC%2BC3cXmtVWns7g%3D
16. B Rannala G Bertorelle 2001 Using linked markers to infer the age of a mutation Hum Mutat 18 2 87 100 11462233 10.1002/humu.1158 1:CAS:528: DC%2BD3MXmslWmtLw%3D (Pubitemid 32726955)